Answers are grounded in this paper and cite their sources.
Longitudinal analysis reveals improvement in HbA1c through reductions in depressive symptoms and enhanced health behaviors in adults with diabetes.
Background Collaborative care models (CoCM) improve both depression and cardiometabolic outcomes, but the mechanisms driving these effects remain unclear. Objective To determine whether changes in depressive symptoms, positive health behaviors (PHBs), body mass index (BMI), and waist circumference mediate the effect of an adapted CoCM on glycemic control among adults with cardiometabolic risk in India. Design Longitudinal structural equation modeling of data from the INtegrating DEPrEssioN and Diabetes TreatmENT (INDEPENDENT) Randomized Control Trial. Participants Adults in India with type 2 diabetes or elevated cardiometabolic risk factors and clinically significant depressive symptoms. Interventions An adapted CoCM integrating behavioral activation (BA) within diabetes care, delivered by a multidisciplinary team to enhance engagement in self-care activities. Main Measures Intervention exposure was the independent variable; mediators were depressive symptoms (Symptom Checklist-20), PHBs (Summary of Diabetes Self-Care Activities), BMI, and waist circumference; the primary outcome was hemoglobin A1c (HbA1c). Confirmatory factor analyses ensured measurement validity, with second-order factors capturing depressive symptom domains (anhedonia, somatization, internalizing symptoms, restlessness). Key Results The intervention significantly reduced depressive symptoms from 0–6 months (β = –0.22, p < 0.01) and 6–12 months (β = –0.34, p < 0.01) and increased PHBs from 0–6 months (β = 0.15, p < 0.05) and 6–12 months (β = 0.11, p < 0.05). Higher depressive symptoms predicted lower PHBs at 6 months (β = –0.26, p < 0.01) and 12 months (β = –0.25, p < 0.01). PHBs mediated reductions in BMI (β = –0.08 to –0.09, p < 0.01) and waist circumference, which in turn mediated improvements in HbA1c. Conclusions An adapted CoCM improved glycemic control and cardiometabolic risk by alleviating depressive symptoms, enhancing PHBs, and reducing BMI and waist circumference. Integrating BA within CoCM may be a key mechanism for optimizing outcomes in integrated cardiometabolic care.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: